Secondary Use of Receipt Data for Drug Safety Measures

Abstract

Any effective drug is accompanied with a risk, and a new risk often becomes clear after marketing in the real world. The Japanese IT new reform strategy aims for what database compilation of receipt and the epidemiological practical use achieve by March 2011. Expectation as information infrastructure for rapid im-provement of drug safety measures rises. Mutual access with medical information of a receipt database and that of each medical facility is indispensable to make a receipt database a useful thing. Under the privacy protection, it becomes an urgent issue to enable pharmacoepidemiological practical use for drug safety measures.